Mobocertinib is an EGFR inhibitor, tailored for NSCLC patients who have those exon 20 insertion mutations. It works by locking on to the EGFR and stopping tumor growth. You get it in these 40 mg capsules.
The recommended daily dose is 160 mg, and that’s all you take once a day. You can take the dose with or without eating. Each bottle is chock-full of 90 capsules.
